202983-32-2CS(=O)(=O)c1cc(S(C)(=O)=O)c2c(NC(=O)c3ccc(NC(=O)c4ccc(NC(=O)Nc5ccc(C(=O)Nc6ccc(C(=O)Nc7ccc(S(C)(=O)=O)c8cc(S(C)(=O)=O)cc(S(C)(=O)=O)c78)cc6)cc5)cc4)cc3)ccc(S(C)(=O)=O)c2c1HFBLZWGWOIKADK-UHFFFAOYSA-NSafety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
UsesNF 279 is a potent and selective P2X1 antagonist.
General DescriptionA suramin analog that acts as a highly selective, competitive, and reversible ATP-antagonist of P2X receptor (IC50/KB ~1 μM in smooth muscle). Effectively discriminates between P2Y and P2X receptors with no discernible effects on α1A adrenoceptors, adenosine A1 and A2B receptors, histamine H1, muscarinic M3 and neuronal nicotinic acetylcholine receptors. Displays a selectivity profile of P2X1 >P2X2 >P2X3 >P2X4 (IC50 = 19 nM, 770 nM, 1.62 μM and >300 μM, respectively) in Xenopus oocytes pre-incubated with ATP. In rat and human tissues, exhibits a potency profile of rat P2X1 > human P2X1 rat P2X2 > rat P2X3 ~human P2X7 human P2X4. Not degraded by ecto-nucleotidases.
No reaction records under the current filter.
Loading…
202983-32-2DTXSID80744273